Aarti Pharmalabs Ltd.

The sales figure stood at Rs. 4709.47 millions for the December 2024 quarter. The mentioned figure indicates a growth of about 26.25% as compared to Rs. 3730.31 millions during the year-ago period.The Profit  for the quarter ended December 2024 of  Rs. 735.23  millions  grew by 52.56% from Rs. 481.94 millions.Operating profit surged to 1269.26 millions from the corresponding previous quarter of 887.38 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202412	202312	% Var	202412	202312	% Var	202403	202303	% Var
Sales	4709.47	3730.31	26.25	12417.27	10873.18	14.20	15021.30	15112.50	-0.60
Other Income	119.36	4.64	2472.41	169.96	53.23	219.29	110.10	12.80	760.16
PBIDT	1269.26	887.38	43.03	3004.14	2441.39	23.05	3571.60	3096.20	15.35
Interest	97.03	43.58	122.65	193.45	122.08	58.46	166.30	204.90	-18.84
PBDT	1172.23	843.80	38.92	2810.69	2319.31	21.19	3405.30	2891.30	17.78
Depreciation	210.43	169.36	24.25	582.29	486.89	19.59	660.10	557.70	18.36
PBT	961.80	674.44	42.61	2228.40	1832.42	21.61	2745.20	2333.60	17.64
TAX	226.57	192.50	17.70	543.36	456.10	19.13	738.70	616.30	19.86
Deferred Tax	51.48	62.50	-17.63	124.66	112.50	10.81	278.10	95.00	192.74
PAT	735.23	481.94	52.56	1685.04	1376.32	22.43	2006.50	1717.30	16.84
Equity	453.13	453.13	0.00	453.13	453.13	0.00	453.10	453.10	0.00
PBIDTM(%)	26.95	23.79	13.30	24.19	22.45	7.75	23.78	20.49	16.05